Health

Impact assessment TBM programme (Applied Biomedical Research) in Flanders

The Flemish programme on Applied Biomedical Research (TBM), funded by the agency for Innovation by Science and Technology (IWT), focuses on a particular niche in biomedical research: Research with a clear societal applicability but limited industrial interest. The programme, initiated in 2006, was oriented towards the development of new therapies, diagnosis and/or specific prevention of…

View report

Assessment of 2007-2013 Ile-de-France Regional Innovation Strategy and definition of its smart specialisation for 2014-2020

Innovation was given an increased weight at EU level in the 2007-2013 programming period. This focus is reinforced for 2014-2020. The National policies developed the last 10 years (Investments for the Future, competitiveness cluster policy) is also geared toward a growing support to innovation. • Assess the outputs of RSI actions co-financed through the ERDF…

View report

Evaluation of Swedish National Research Programmes for the Pharmaceutical, Biotechnology and Medical Technology Industries

The Swedish national research programmes for the pharmaceutical, biotechnology and medical technology industries, SAMBIO and SAMPOST, had their origins in the national innovation strategy ‘Innovative Sweden’ from 2004 and the subsequent national sectoral strategy Pharmaceuticals, Biotechnology and Medical Technology from 2005. The aim of this evaluation by Technopolis Group was to assess whether the programmes’…

View report

Norwegian motives for participation in the Framework Programme

The Norwegian Ministry for Education and Research commissioned Technopolis Group to conduct a study on motives and deterrents for Norwegian participation in the framework programme (FP), focusing on FP7 Health, ICT and Environment themes.  The study found that Norwegian stakeholders largely share both their main motives for FP participation with their counterparts elsewhere (in no…

View report

Study on measuring the multiplier effect of NGI investments

The Netherlands Genomics Initiative (NGI) was founded in January 2002, with a view to advancing the performance and application of genomics research in the Netherlands. NGI aims to promote both the performance of genomics research in the Netherlands and its application by developing an excellent research infrastructure consisting of leading Dutch research groups in the…

View report

An Analysis of Alternative Governance Models for the Innovative Medical Devices Initiative in The Netherlands

The Dutch health research funder, Zon MW,  asked Technopolis to perform a prospective analysis of alternative governance models for its innovative medical devices initiative (IMDI). IMDI has the purpose of strengthening the Dutch knowledge infrastructure in the field of medical devices. Through the development of new medical devices, IMDI.nl aimed to: Contribute to public health:…

View report

Evaluation of the Innovationsbron programme to support develoment projects in academic research environments

Technopolis Group conducted an evaluation of the Innovationsbron programme on utilisation of research results in life science. The evaluation included 357 projects adopted by Innovationsbron over the period 2007-2010 . The number of approved projects varied between 67 and 110 per year during the period. The results in this study were based on studies of…

View report

Analysis of the societal potential for the Dutch domain on Brain and Cognition research

In 2009, the Temporary Task Force on Brain and Cognition (Nationaal Initiatief Hersenen & Cognitie) was established. The task force was built around a number of research funding programmes and focus on three clusters health, education and safety. The Task Force commissioned Technopolis Group to conduct an explorative study on the societal potential of the…

View report